The $750,000 grant award will support continued collaborative research and development between EncorePharma and researchers at the Oklahoma Medical Research Foundation (OMFR). In addition, the phase 2 grant
This trial is designed to specifically assess the safety and efficacy of OGX-011 in tandem with gemcitabine and cisplatin, a commonly used chemotherapeutic regimen, in patients with non-small
The research demonstrates that a protein called P-selectin could be an important factor in blood clotting. Furthermore, by altering its levels in the bloodstream the investigators were able
Chemiphar will retain commercialization rights in Asia for any new product candidates, while Velcura will have commercialization rights in the US, Europe and all other markets outside Asia.
Researchers from Monash University in Australia have succeeded in revitalizing the thymus which produces the T cells required to fight infection but which shuts down from early adulthood.
Several forms of anticancer therapy rely on what is known as immunotherapeutic anticancer strategies; therapies that encourage the body’s natural defenses, such as cytotoxic T lymphocytes, to aid
The vaccine, being developed by AvaxisBio, is made from small peptide molecules based on portions of the Variola virus genome selected for optimal effects on the human immune
In exchange for the license it has obtained, the company will pay an upfront fee as well as milestone and royalty payments to the US National Research Council
In the collaborations, scientists at Orion and Washington University will focus on the most common cancers including lung, breast, cervical, prostate and ovarian cancer and will look for
The company is particularly interested in a new biological target that has been identified by the university researchers to play an important role in the progression of the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.